Global TB Disease Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Gu?rin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
LPI (LP Information)' newest research report, the “TB Disease Vaccine Industry Forecast” looks at past sales and reviews total world TB Disease Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected TB Disease Vaccine sales for 2023 through 2029. With TB Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TB Disease Vaccine industry.
This Insight Report provides a comprehensive analysis of the global TB Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TB Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global TB Disease Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TB Disease Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TB Disease Vaccine.
The global TB Disease Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for TB Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for TB Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for TB Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key TB Disease Vaccine players cover Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of TB Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global TB Disease Vaccine market?
What factors are driving TB Disease Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TB Disease Vaccine market opportunities vary by end market size?
How does TB Disease Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The vaccine for tuberculosis (TB) is known as BCG (bacille Calmette-Gu?rin) vaccine. BCG vaccine contains a weakened form of the bacteria (germ) that cause TB. Because it is weakened it doesn't cause TB in healthy people but it helps develop some protection (immunity) against TB.
LPI (LP Information)' newest research report, the “TB Disease Vaccine Industry Forecast” looks at past sales and reviews total world TB Disease Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected TB Disease Vaccine sales for 2023 through 2029. With TB Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TB Disease Vaccine industry.
This Insight Report provides a comprehensive analysis of the global TB Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TB Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global TB Disease Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TB Disease Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TB Disease Vaccine.
The global TB Disease Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for TB Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for TB Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for TB Disease Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key TB Disease Vaccine players cover Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of TB Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Prevention Vaccines
- Post-exposure Vaccines
- Others
- Self-Procurement
- UNICEF
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Japan BCG Lab
- Serum Institute of India
- AJ Vaccines
- BioFarma
- GreenSignal Bio Pharma
- China National Biotec
- Biomed Lublin
- Taj Pharmaceuticals
- Ataulpho de Paiva
- IVAC
- Queen Saovabha Mem. Inst
- Microgen
What is the 10-year outlook for the global TB Disease Vaccine market?
What factors are driving TB Disease Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TB Disease Vaccine market opportunities vary by end market size?
How does TB Disease Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TB Disease Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for TB Disease Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for TB Disease Vaccine by Country/Region, 2018, 2022 & 2029
2.2 TB Disease Vaccine Segment by Type
2.2.1 Prevention Vaccines
2.2.2 Post-exposure Vaccines
2.2.3 Others
2.3 TB Disease Vaccine Sales by Type
2.3.1 Global TB Disease Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global TB Disease Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global TB Disease Vaccine Sale Price by Type (2018-2023)
2.4 TB Disease Vaccine Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Others
2.5 TB Disease Vaccine Sales by Application
2.5.1 Global TB Disease Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global TB Disease Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global TB Disease Vaccine Sale Price by Application (2018-2023)
3 GLOBAL TB DISEASE VACCINE BY COMPANY
3.1 Global TB Disease Vaccine Breakdown Data by Company
3.1.1 Global TB Disease Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global TB Disease Vaccine Sales Market Share by Company (2018-2023)
3.2 Global TB Disease Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global TB Disease Vaccine Revenue by Company (2018-2023)
3.2.2 Global TB Disease Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global TB Disease Vaccine Sale Price by Company
3.4 Key Manufacturers TB Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TB Disease Vaccine Product Location Distribution
3.4.2 Players TB Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TB DISEASE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic TB Disease Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global TB Disease Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global TB Disease Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic TB Disease Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global TB Disease Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global TB Disease Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas TB Disease Vaccine Sales Growth
4.4 APAC TB Disease Vaccine Sales Growth
4.5 Europe TB Disease Vaccine Sales Growth
4.6 Middle East & Africa TB Disease Vaccine Sales Growth
5 AMERICAS
5.1 Americas TB Disease Vaccine Sales by Country
5.1.1 Americas TB Disease Vaccine Sales by Country (2018-2023)
5.1.2 Americas TB Disease Vaccine Revenue by Country (2018-2023)
5.2 Americas TB Disease Vaccine Sales by Type
5.3 Americas TB Disease Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TB Disease Vaccine Sales by Region
6.1.1 APAC TB Disease Vaccine Sales by Region (2018-2023)
6.1.2 APAC TB Disease Vaccine Revenue by Region (2018-2023)
6.2 APAC TB Disease Vaccine Sales by Type
6.3 APAC TB Disease Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe TB Disease Vaccine by Country
7.1.1 Europe TB Disease Vaccine Sales by Country (2018-2023)
7.1.2 Europe TB Disease Vaccine Revenue by Country (2018-2023)
7.2 Europe TB Disease Vaccine Sales by Type
7.3 Europe TB Disease Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TB Disease Vaccine by Country
8.1.1 Middle East & Africa TB Disease Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa TB Disease Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa TB Disease Vaccine Sales by Type
8.3 Middle East & Africa TB Disease Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TB Disease Vaccine
10.3 Manufacturing Process Analysis of TB Disease Vaccine
10.4 Industry Chain Structure of TB Disease Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TB Disease Vaccine Distributors
11.3 TB Disease Vaccine Customer
12 WORLD FORECAST REVIEW FOR TB DISEASE VACCINE BY GEOGRAPHIC REGION
12.1 Global TB Disease Vaccine Market Size Forecast by Region
12.1.1 Global TB Disease Vaccine Forecast by Region (2024-2029)
12.1.2 Global TB Disease Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global TB Disease Vaccine Forecast by Type
12.7 Global TB Disease Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck TB Disease Vaccine Product Portfolios and Specifications
13.1.3 Merck TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab TB Disease Vaccine Product Portfolios and Specifications
13.2.3 Japan BCG Lab TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India TB Disease Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines TB Disease Vaccine Product Portfolios and Specifications
13.4.3 AJ Vaccines TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma TB Disease Vaccine Product Portfolios and Specifications
13.5.3 BioFarma TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma TB Disease Vaccine Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec TB Disease Vaccine Product Portfolios and Specifications
13.7.3 China National Biotec TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin TB Disease Vaccine Product Portfolios and Specifications
13.8.3 Biomed Lublin TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals TB Disease Vaccine Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva TB Disease Vaccine Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC
13.11.1 IVAC Company Information
13.11.2 IVAC TB Disease Vaccine Product Portfolios and Specifications
13.11.3 IVAC TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 IVAC Main Business Overview
13.11.5 IVAC Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst TB Disease Vaccine Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen TB Disease Vaccine Product Portfolios and Specifications
13.13.3 Microgen TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TB Disease Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for TB Disease Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for TB Disease Vaccine by Country/Region, 2018, 2022 & 2029
2.2 TB Disease Vaccine Segment by Type
2.2.1 Prevention Vaccines
2.2.2 Post-exposure Vaccines
2.2.3 Others
2.3 TB Disease Vaccine Sales by Type
2.3.1 Global TB Disease Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global TB Disease Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global TB Disease Vaccine Sale Price by Type (2018-2023)
2.4 TB Disease Vaccine Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Others
2.5 TB Disease Vaccine Sales by Application
2.5.1 Global TB Disease Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global TB Disease Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global TB Disease Vaccine Sale Price by Application (2018-2023)
3 GLOBAL TB DISEASE VACCINE BY COMPANY
3.1 Global TB Disease Vaccine Breakdown Data by Company
3.1.1 Global TB Disease Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global TB Disease Vaccine Sales Market Share by Company (2018-2023)
3.2 Global TB Disease Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global TB Disease Vaccine Revenue by Company (2018-2023)
3.2.2 Global TB Disease Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global TB Disease Vaccine Sale Price by Company
3.4 Key Manufacturers TB Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TB Disease Vaccine Product Location Distribution
3.4.2 Players TB Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TB DISEASE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic TB Disease Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global TB Disease Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global TB Disease Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic TB Disease Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global TB Disease Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global TB Disease Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas TB Disease Vaccine Sales Growth
4.4 APAC TB Disease Vaccine Sales Growth
4.5 Europe TB Disease Vaccine Sales Growth
4.6 Middle East & Africa TB Disease Vaccine Sales Growth
5 AMERICAS
5.1 Americas TB Disease Vaccine Sales by Country
5.1.1 Americas TB Disease Vaccine Sales by Country (2018-2023)
5.1.2 Americas TB Disease Vaccine Revenue by Country (2018-2023)
5.2 Americas TB Disease Vaccine Sales by Type
5.3 Americas TB Disease Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TB Disease Vaccine Sales by Region
6.1.1 APAC TB Disease Vaccine Sales by Region (2018-2023)
6.1.2 APAC TB Disease Vaccine Revenue by Region (2018-2023)
6.2 APAC TB Disease Vaccine Sales by Type
6.3 APAC TB Disease Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe TB Disease Vaccine by Country
7.1.1 Europe TB Disease Vaccine Sales by Country (2018-2023)
7.1.2 Europe TB Disease Vaccine Revenue by Country (2018-2023)
7.2 Europe TB Disease Vaccine Sales by Type
7.3 Europe TB Disease Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TB Disease Vaccine by Country
8.1.1 Middle East & Africa TB Disease Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa TB Disease Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa TB Disease Vaccine Sales by Type
8.3 Middle East & Africa TB Disease Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TB Disease Vaccine
10.3 Manufacturing Process Analysis of TB Disease Vaccine
10.4 Industry Chain Structure of TB Disease Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TB Disease Vaccine Distributors
11.3 TB Disease Vaccine Customer
12 WORLD FORECAST REVIEW FOR TB DISEASE VACCINE BY GEOGRAPHIC REGION
12.1 Global TB Disease Vaccine Market Size Forecast by Region
12.1.1 Global TB Disease Vaccine Forecast by Region (2024-2029)
12.1.2 Global TB Disease Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global TB Disease Vaccine Forecast by Type
12.7 Global TB Disease Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck TB Disease Vaccine Product Portfolios and Specifications
13.1.3 Merck TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab TB Disease Vaccine Product Portfolios and Specifications
13.2.3 Japan BCG Lab TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India TB Disease Vaccine Product Portfolios and Specifications
13.3.3 Serum Institute of India TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines TB Disease Vaccine Product Portfolios and Specifications
13.4.3 AJ Vaccines TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma TB Disease Vaccine Product Portfolios and Specifications
13.5.3 BioFarma TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma TB Disease Vaccine Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec TB Disease Vaccine Product Portfolios and Specifications
13.7.3 China National Biotec TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin TB Disease Vaccine Product Portfolios and Specifications
13.8.3 Biomed Lublin TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals TB Disease Vaccine Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva TB Disease Vaccine Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC
13.11.1 IVAC Company Information
13.11.2 IVAC TB Disease Vaccine Product Portfolios and Specifications
13.11.3 IVAC TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 IVAC Main Business Overview
13.11.5 IVAC Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst TB Disease Vaccine Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen TB Disease Vaccine Product Portfolios and Specifications
13.13.3 Microgen TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. TB Disease Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. TB Disease Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Prevention Vaccines
Table 4. Major Players of Post-exposure Vaccines
Table 5. Major Players of Others
Table 6. Global TB Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 7. Global TB Disease Vaccine Sales Market Share by Type (2018-2023)
Table 8. Global TB Disease Vaccine Revenue by Type (2018-2023) & ($ million)
Table 9. Global TB Disease Vaccine Revenue Market Share by Type (2018-2023)
Table 10. Global TB Disease Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global TB Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 12. Global TB Disease Vaccine Sales Market Share by Application (2018-2023)
Table 13. Global TB Disease Vaccine Revenue by Application (2018-2023)
Table 14. Global TB Disease Vaccine Revenue Market Share by Application (2018-2023)
Table 15. Global TB Disease Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global TB Disease Vaccine Sales by Company (2018-2023) & (K Units)
Table 17. Global TB Disease Vaccine Sales Market Share by Company (2018-2023)
Table 18. Global TB Disease Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global TB Disease Vaccine Revenue Market Share by Company (2018-2023)
Table 20. Global TB Disease Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers TB Disease Vaccine Producing Area Distribution and Sales Area
Table 22. Players TB Disease Vaccine Products Offered
Table 23. TB Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global TB Disease Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global TB Disease Vaccine Sales Market Share Geographic Region (2018-2023)
Table 28. Global TB Disease Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global TB Disease Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global TB Disease Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global TB Disease Vaccine Sales Market Share by Country/Region (2018-2023)
Table 32. Global TB Disease Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global TB Disease Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas TB Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 35. Americas TB Disease Vaccine Sales Market Share by Country (2018-2023)
Table 36. Americas TB Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas TB Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 38. Americas TB Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 39. Americas TB Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 40. APAC TB Disease Vaccine Sales by Region (2018-2023) & (K Units)
Table 41. APAC TB Disease Vaccine Sales Market Share by Region (2018-2023)
Table 42. APAC TB Disease Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC TB Disease Vaccine Revenue Market Share by Region (2018-2023)
Table 44. APAC TB Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 45. APAC TB Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 46. Europe TB Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Europe TB Disease Vaccine Sales Market Share by Country (2018-2023)
Table 48. Europe TB Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe TB Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 50. Europe TB Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 51. Europe TB Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa TB Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa TB Disease Vaccine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa TB Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa TB Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa TB Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa TB Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of TB Disease Vaccine
Table 59. Key Market Challenges & Risks of TB Disease Vaccine
Table 60. Key Industry Trends of TB Disease Vaccine
Table 61. TB Disease Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. TB Disease Vaccine Distributors List
Table 64. TB Disease Vaccine Customer List
Table 65. Global TB Disease Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global TB Disease Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas TB Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas TB Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC TB Disease Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC TB Disease Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe TB Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe TB Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa TB Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa TB Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global TB Disease Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global TB Disease Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global TB Disease Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global TB Disease Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck TB Disease Vaccine Product Portfolios and Specifications
Table 81. Merck TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Japan BCG Lab Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Japan BCG Lab TB Disease Vaccine Product Portfolios and Specifications
Table 86. Japan BCG Lab TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Japan BCG Lab Main Business
Table 88. Japan BCG Lab Latest Developments
Table 89. Serum Institute of India Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Serum Institute of India TB Disease Vaccine Product Portfolios and Specifications
Table 91. Serum Institute of India TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Serum Institute of India Main Business
Table 93. Serum Institute of India Latest Developments
Table 94. AJ Vaccines Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. AJ Vaccines TB Disease Vaccine Product Portfolios and Specifications
Table 96. AJ Vaccines TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. AJ Vaccines Main Business
Table 98. AJ Vaccines Latest Developments
Table 99. BioFarma Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. BioFarma TB Disease Vaccine Product Portfolios and Specifications
Table 101. BioFarma TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. BioFarma Main Business
Table 103. BioFarma Latest Developments
Table 104. GreenSignal Bio Pharma Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. GreenSignal Bio Pharma TB Disease Vaccine Product Portfolios and Specifications
Table 106. GreenSignal Bio Pharma TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. GreenSignal Bio Pharma Main Business
Table 108. GreenSignal Bio Pharma Latest Developments
Table 109. China National Biotec Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. China National Biotec TB Disease Vaccine Product Portfolios and Specifications
Table 111. China National Biotec TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. China National Biotec Main Business
Table 113. China National Biotec Latest Developments
Table 114. Biomed Lublin Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Biomed Lublin TB Disease Vaccine Product Portfolios and Specifications
Table 116. Biomed Lublin TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Biomed Lublin Main Business
Table 118. Biomed Lublin Latest Developments
Table 119. Taj Pharmaceuticals Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. Taj Pharmaceuticals TB Disease Vaccine Product Portfolios and Specifications
Table 121. Taj Pharmaceuticals TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Taj Pharmaceuticals Main Business
Table 123. Taj Pharmaceuticals Latest Developments
Table 124. Ataulpho de Paiva Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. Ataulpho de Paiva TB Disease Vaccine Product Portfolios and Specifications
Table 126. Ataulpho de Paiva TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Ataulpho de Paiva Main Business
Table 128. Ataulpho de Paiva Latest Developments
Table 129. IVAC Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. IVAC TB Disease Vaccine Product Portfolios and Specifications
Table 131. IVAC TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. IVAC Main Business
Table 133. IVAC Latest Developments
Table 134. Queen Saovabha Mem. Inst Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. Queen Saovabha Mem. Inst TB Disease Vaccine Product Portfolios and Specifications
Table 136. Queen Saovabha Mem. Inst TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Queen Saovabha Mem. Inst Main Business
Table 138. Queen Saovabha Mem. Inst Latest Developments
Table 139. Microgen Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. Microgen TB Disease Vaccine Product Portfolios and Specifications
Table 141. Microgen TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Microgen Main Business
Table 143. Microgen Latest Developments
Table 1. TB Disease Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. TB Disease Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Prevention Vaccines
Table 4. Major Players of Post-exposure Vaccines
Table 5. Major Players of Others
Table 6. Global TB Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 7. Global TB Disease Vaccine Sales Market Share by Type (2018-2023)
Table 8. Global TB Disease Vaccine Revenue by Type (2018-2023) & ($ million)
Table 9. Global TB Disease Vaccine Revenue Market Share by Type (2018-2023)
Table 10. Global TB Disease Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global TB Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 12. Global TB Disease Vaccine Sales Market Share by Application (2018-2023)
Table 13. Global TB Disease Vaccine Revenue by Application (2018-2023)
Table 14. Global TB Disease Vaccine Revenue Market Share by Application (2018-2023)
Table 15. Global TB Disease Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global TB Disease Vaccine Sales by Company (2018-2023) & (K Units)
Table 17. Global TB Disease Vaccine Sales Market Share by Company (2018-2023)
Table 18. Global TB Disease Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 19. Global TB Disease Vaccine Revenue Market Share by Company (2018-2023)
Table 20. Global TB Disease Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers TB Disease Vaccine Producing Area Distribution and Sales Area
Table 22. Players TB Disease Vaccine Products Offered
Table 23. TB Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global TB Disease Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global TB Disease Vaccine Sales Market Share Geographic Region (2018-2023)
Table 28. Global TB Disease Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global TB Disease Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global TB Disease Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global TB Disease Vaccine Sales Market Share by Country/Region (2018-2023)
Table 32. Global TB Disease Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global TB Disease Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas TB Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 35. Americas TB Disease Vaccine Sales Market Share by Country (2018-2023)
Table 36. Americas TB Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas TB Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 38. Americas TB Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 39. Americas TB Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 40. APAC TB Disease Vaccine Sales by Region (2018-2023) & (K Units)
Table 41. APAC TB Disease Vaccine Sales Market Share by Region (2018-2023)
Table 42. APAC TB Disease Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC TB Disease Vaccine Revenue Market Share by Region (2018-2023)
Table 44. APAC TB Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 45. APAC TB Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 46. Europe TB Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Europe TB Disease Vaccine Sales Market Share by Country (2018-2023)
Table 48. Europe TB Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe TB Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 50. Europe TB Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 51. Europe TB Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa TB Disease Vaccine Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa TB Disease Vaccine Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa TB Disease Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa TB Disease Vaccine Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa TB Disease Vaccine Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa TB Disease Vaccine Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of TB Disease Vaccine
Table 59. Key Market Challenges & Risks of TB Disease Vaccine
Table 60. Key Industry Trends of TB Disease Vaccine
Table 61. TB Disease Vaccine Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. TB Disease Vaccine Distributors List
Table 64. TB Disease Vaccine Customer List
Table 65. Global TB Disease Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global TB Disease Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas TB Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas TB Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC TB Disease Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC TB Disease Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe TB Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe TB Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa TB Disease Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa TB Disease Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global TB Disease Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global TB Disease Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global TB Disease Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global TB Disease Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck TB Disease Vaccine Product Portfolios and Specifications
Table 81. Merck TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Japan BCG Lab Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Japan BCG Lab TB Disease Vaccine Product Portfolios and Specifications
Table 86. Japan BCG Lab TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Japan BCG Lab Main Business
Table 88. Japan BCG Lab Latest Developments
Table 89. Serum Institute of India Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Serum Institute of India TB Disease Vaccine Product Portfolios and Specifications
Table 91. Serum Institute of India TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Serum Institute of India Main Business
Table 93. Serum Institute of India Latest Developments
Table 94. AJ Vaccines Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 95. AJ Vaccines TB Disease Vaccine Product Portfolios and Specifications
Table 96. AJ Vaccines TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. AJ Vaccines Main Business
Table 98. AJ Vaccines Latest Developments
Table 99. BioFarma Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 100. BioFarma TB Disease Vaccine Product Portfolios and Specifications
Table 101. BioFarma TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. BioFarma Main Business
Table 103. BioFarma Latest Developments
Table 104. GreenSignal Bio Pharma Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 105. GreenSignal Bio Pharma TB Disease Vaccine Product Portfolios and Specifications
Table 106. GreenSignal Bio Pharma TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. GreenSignal Bio Pharma Main Business
Table 108. GreenSignal Bio Pharma Latest Developments
Table 109. China National Biotec Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 110. China National Biotec TB Disease Vaccine Product Portfolios and Specifications
Table 111. China National Biotec TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. China National Biotec Main Business
Table 113. China National Biotec Latest Developments
Table 114. Biomed Lublin Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 115. Biomed Lublin TB Disease Vaccine Product Portfolios and Specifications
Table 116. Biomed Lublin TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Biomed Lublin Main Business
Table 118. Biomed Lublin Latest Developments
Table 119. Taj Pharmaceuticals Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 120. Taj Pharmaceuticals TB Disease Vaccine Product Portfolios and Specifications
Table 121. Taj Pharmaceuticals TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Taj Pharmaceuticals Main Business
Table 123. Taj Pharmaceuticals Latest Developments
Table 124. Ataulpho de Paiva Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 125. Ataulpho de Paiva TB Disease Vaccine Product Portfolios and Specifications
Table 126. Ataulpho de Paiva TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Ataulpho de Paiva Main Business
Table 128. Ataulpho de Paiva Latest Developments
Table 129. IVAC Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 130. IVAC TB Disease Vaccine Product Portfolios and Specifications
Table 131. IVAC TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. IVAC Main Business
Table 133. IVAC Latest Developments
Table 134. Queen Saovabha Mem. Inst Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 135. Queen Saovabha Mem. Inst TB Disease Vaccine Product Portfolios and Specifications
Table 136. Queen Saovabha Mem. Inst TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Queen Saovabha Mem. Inst Main Business
Table 138. Queen Saovabha Mem. Inst Latest Developments
Table 139. Microgen Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 140. Microgen TB Disease Vaccine Product Portfolios and Specifications
Table 141. Microgen TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Microgen Main Business
Table 143. Microgen Latest Developments
LIST OF FIGURES
Figure 1. Picture of TB Disease Vaccine
Figure 2. TB Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global TB Disease Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global TB Disease Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. TB Disease Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Prevention Vaccines
Figure 10. Product Picture of Post-exposure Vaccines
Figure 11. Product Picture of Others
Figure 12. Global TB Disease Vaccine Sales Market Share by Type in 2022
Figure 13. Global TB Disease Vaccine Revenue Market Share by Type (2018-2023)
Figure 14. TB Disease Vaccine Consumed in Self-Procurement
Figure 15. Global TB Disease Vaccine Market: Self-Procurement (2018-2023) & (K Units)
Figure 16. TB Disease Vaccine Consumed in UNICEF
Figure 17. Global TB Disease Vaccine Market: UNICEF (2018-2023) & (K Units)
Figure 18. TB Disease Vaccine Consumed in Others
Figure 19. Global TB Disease Vaccine Market: Others (2018-2023) & (K Units)
Figure 20. Global TB Disease Vaccine Sales Market Share by Application (2022)
Figure 21. Global TB Disease Vaccine Revenue Market Share by Application in 2022
Figure 22. TB Disease Vaccine Sales Market by Company in 2022 (K Units)
Figure 23. Global TB Disease Vaccine Sales Market Share by Company in 2022
Figure 24. TB Disease Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 25. Global TB Disease Vaccine Revenue Market Share by Company in 2022
Figure 26. Global TB Disease Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global TB Disease Vaccine Revenue Market Share by Geographic Region in 2022
Figure 28. Americas TB Disease Vaccine Sales 2018-2023 (K Units)
Figure 29. Americas TB Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 30. APAC TB Disease Vaccine Sales 2018-2023 (K Units)
Figure 31. APAC TB Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 32. Europe TB Disease Vaccine Sales 2018-2023 (K Units)
Figure 33. Europe TB Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa TB Disease Vaccine Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa TB Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 36. Americas TB Disease Vaccine Sales Market Share by Country in 2022
Figure 37. Americas TB Disease Vaccine Revenue Market Share by Country in 2022
Figure 38. Americas TB Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 39. Americas TB Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 40. United States TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC TB Disease Vaccine Sales Market Share by Region in 2022
Figure 45. APAC TB Disease Vaccine Revenue Market Share by Regions in 2022
Figure 46. APAC TB Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 47. APAC TB Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 48. China TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. India TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe TB Disease Vaccine Sales Market Share by Country in 2022
Figure 56. Europe TB Disease Vaccine Revenue Market Share by Country in 2022
Figure 57. Europe TB Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 58. Europe TB Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 59. Germany TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. France TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa TB Disease Vaccine Sales Market Share by Country in 2022
Figure 65. Middle East & Africa TB Disease Vaccine Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa TB Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa TB Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 68. Egypt TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of TB Disease Vaccine in 2022
Figure 74. Manufacturing Process Analysis of TB Disease Vaccine
Figure 75. Industry Chain Structure of TB Disease Vaccine
Figure 76. Channels of Distribution
Figure 77. Global TB Disease Vaccine Sales Market Forecast by Region (2024-2029)
Figure 78. Global TB Disease Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global TB Disease Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global TB Disease Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global TB Disease Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global TB Disease Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of TB Disease Vaccine
Figure 2. TB Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global TB Disease Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global TB Disease Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. TB Disease Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Prevention Vaccines
Figure 10. Product Picture of Post-exposure Vaccines
Figure 11. Product Picture of Others
Figure 12. Global TB Disease Vaccine Sales Market Share by Type in 2022
Figure 13. Global TB Disease Vaccine Revenue Market Share by Type (2018-2023)
Figure 14. TB Disease Vaccine Consumed in Self-Procurement
Figure 15. Global TB Disease Vaccine Market: Self-Procurement (2018-2023) & (K Units)
Figure 16. TB Disease Vaccine Consumed in UNICEF
Figure 17. Global TB Disease Vaccine Market: UNICEF (2018-2023) & (K Units)
Figure 18. TB Disease Vaccine Consumed in Others
Figure 19. Global TB Disease Vaccine Market: Others (2018-2023) & (K Units)
Figure 20. Global TB Disease Vaccine Sales Market Share by Application (2022)
Figure 21. Global TB Disease Vaccine Revenue Market Share by Application in 2022
Figure 22. TB Disease Vaccine Sales Market by Company in 2022 (K Units)
Figure 23. Global TB Disease Vaccine Sales Market Share by Company in 2022
Figure 24. TB Disease Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 25. Global TB Disease Vaccine Revenue Market Share by Company in 2022
Figure 26. Global TB Disease Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global TB Disease Vaccine Revenue Market Share by Geographic Region in 2022
Figure 28. Americas TB Disease Vaccine Sales 2018-2023 (K Units)
Figure 29. Americas TB Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 30. APAC TB Disease Vaccine Sales 2018-2023 (K Units)
Figure 31. APAC TB Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 32. Europe TB Disease Vaccine Sales 2018-2023 (K Units)
Figure 33. Europe TB Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa TB Disease Vaccine Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa TB Disease Vaccine Revenue 2018-2023 ($ Millions)
Figure 36. Americas TB Disease Vaccine Sales Market Share by Country in 2022
Figure 37. Americas TB Disease Vaccine Revenue Market Share by Country in 2022
Figure 38. Americas TB Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 39. Americas TB Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 40. United States TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC TB Disease Vaccine Sales Market Share by Region in 2022
Figure 45. APAC TB Disease Vaccine Revenue Market Share by Regions in 2022
Figure 46. APAC TB Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 47. APAC TB Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 48. China TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. India TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe TB Disease Vaccine Sales Market Share by Country in 2022
Figure 56. Europe TB Disease Vaccine Revenue Market Share by Country in 2022
Figure 57. Europe TB Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 58. Europe TB Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 59. Germany TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. France TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa TB Disease Vaccine Sales Market Share by Country in 2022
Figure 65. Middle East & Africa TB Disease Vaccine Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa TB Disease Vaccine Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa TB Disease Vaccine Sales Market Share by Application (2018-2023)
Figure 68. Egypt TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country TB Disease Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of TB Disease Vaccine in 2022
Figure 74. Manufacturing Process Analysis of TB Disease Vaccine
Figure 75. Industry Chain Structure of TB Disease Vaccine
Figure 76. Channels of Distribution
Figure 77. Global TB Disease Vaccine Sales Market Forecast by Region (2024-2029)
Figure 78. Global TB Disease Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global TB Disease Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global TB Disease Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global TB Disease Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global TB Disease Vaccine Revenue Market Share Forecast by Application (2024-2029)
